ITEOS THERAPEUTICS INC's ticker is ITOS and the CUSIP is 46565G104. A total of 55 filers reported holding ITEOS THERAPEUTICS INC in Q3 2020. The put-call ratio across all filers is - and the average weighting 0.8%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $386,754 | -21.2% | 35,320 | -4.7% | 0.00% | – |
| Q2 2023 | $490,674 | +42.5% | 37,060 | +46.5% | 0.00% | – |
| Q1 2023 | $344,333 | -39.0% | 25,300 | -12.5% | 0.00% | – |
| Q4 2022 | $564,847 | -59.2% | 28,922 | -60.3% | 0.00% | -100.0% |
| Q3 2022 | $1,386,000 | -89.3% | 72,779 | -88.5% | 0.00% | -83.3% |
| Q2 2022 | $13,001,000 | -63.8% | 631,118 | -43.5% | 0.01% | -57.1% |
| Q1 2022 | $35,956,000 | -40.8% | 1,117,346 | -14.4% | 0.01% | -33.3% |
| Q4 2021 | $60,771,000 | +68.6% | 1,305,213 | -2.2% | 0.02% | +50.0% |
| Q3 2021 | $36,047,000 | +3.7% | 1,335,081 | -1.5% | 0.01% | 0.0% |
| Q2 2021 | $34,758,000 | -13.1% | 1,355,078 | +15.8% | 0.01% | -22.2% |
| Q1 2021 | $39,991,000 | +7.7% | 1,170,001 | +6.5% | 0.02% | 0.0% |
| Q4 2020 | $37,138,000 | +96.0% | 1,098,100 | +43.0% | 0.02% | +80.0% |
| Q3 2020 | $18,949,000 | – | 768,084 | – | 0.01% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| MPM ASSET MANAGEMENT LLC | 2,738,785 | $37,274,864 | 15.53% |
| MPM BioImpact LLC | 1,745,943 | $23,762,284 | 6.17% |
| Saturn V Capital Management LP | 480,653 | $6,541,687 | 4.89% |
| Boxer Capital, LLC | 2,154,058 | $29,317 | 1.44% |
| RA Capital Management | 4,417,259 | $60,118,895 | 1.36% |
| Octagon Capital Advisors LP | 596,000 | $8,111,560 | 1.17% |
| BVF INC/IL | 1,810,835 | $24,645,464 | 0.90% |
| AlphaCentric Advisors LLC | 63,000 | $857,430 | 0.59% |
| Integral Health Asset Management, LLC | 180,000 | $2,449,800 | 0.49% |
| 683 Capital Management, LLC | 480,000 | $6,532,800 | 0.49% |